West Pharmaceutical Services Inc
West Pharmaceutical Services Inc (WST) supplies components and delivery systems for injectable drugs and vaccines, including stoppers, seals, syringe components and containment technologies. Its customers are pharmaceutical and biotechnology companies that rely on high-quality, regulatory-compliant components for sterile drug packaging and drug delivery. West benefits from long-term trends such as growth in biologic medicines, injectable therapeutics and outsourcing of containment and delivery manufacturing, supporting steady demand for precision components. Investors should note the company operates in a manufacturing- and technology-intensive niche where quality, regulatory approval and supply-chain resilience are key competitive advantages. Financially, West is a mid-cap company (market cap approx. $20.1bn) with a history of generating operating cash flow, though revenues can be influenced by customers' development cycles and contract timing. Key risks include regulatory scrutiny, competition, raw-material and manufacturing disruptions, and customer concentration. This summary is educational only and not personalised investment advice; perform your own due diligence.
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying West Pharmaceutical Services' stock with a target price of $349.79, indicating growth potential.
Financial Health
West Pharmaceutical Services is producing solid revenue and cash flow, indicating effective business operations.
Dividend
West Pharmaceutical's low dividend yield of 0.35% means it's not the best choice for dividend seekers. If you invested $1000 you would be paid $3.50 a year in dividends (based on the last 12 months).
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring WST
Global Pharma Titans | Brazil Healthcare Investment
Brazil's large and innovative pharmaceutical market presents a significant area of interest for those looking at global healthcare trends. This basket provides exposure to leading US and EU-listed pharmaceutical and biotech companies with substantial operations, partnerships, or sales within Brazil.
Published: October 16, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Demand from biologics
Biologic and injectable drug growth supports long-term demand for precision components, though revenue timing can vary with customers' development cycles.
Quality and execution
Manufacturing excellence and regulatory compliance are competitive advantages, but execution and supply‑chain disruptions can materially affect results.
Exposure to pharma
West offers indirect exposure to global pharmaceutical and biotech activity, balanced by risks such as customer concentration and regulatory scrutiny.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. It offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
